{"id":5904,"date":"2025-03-07T17:16:40","date_gmt":"2025-03-07T14:16:40","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=5904"},"modified":"2025-03-07T17:16:57","modified_gmt":"2025-03-07T14:16:57","slug":"cabg-still-the-gold-standard-for-revascularization-in-patients-with-3-vessel-cad-and-ckd","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/cabg-still-the-gold-standard-for-revascularization-in-patients-with-3-vessel-cad-and-ckd\/","title":{"rendered":"CABG still the \u2018gold standard\u2019 for revascularization in patients with 3-vessel CAD and CKD."},"content":{"rendered":"<div>CABG still the \u2018gold standard\u2019 for revascularization in patients with 3-vessel CAD and CKD.<\/div>\n<div>CABG Provides Superior Long-Term Outcomes Compared to PCI in Patients with TVD and CKD<\/div>\n<div><\/div>\n<div>Publication was released by the AHA via its official outlets \/February 19, 2025.<\/div>\n<div><\/div>\n<div>A new study published in The American Journal of Cardiology confirms that coronary artery bypass grafting (CABG) offers better long-term outcomes than percutaneous coronary intervention (PCI) in patients with three-vessel coronary artery disease (TVD) and chronic kidney disease (CKD). While mid-term benefits of CABG over PCI were previously established, this study extends the evidence to longer follow-up intervals.<\/div>\n<div><\/div>\n<div>Key Findings:<\/div>\n<div><span> \u2022 Study population: 400+ patients treated between 2009 and 2018 in Alberta, Canada.<\/span><\/div>\n<div><span> \u2022 PCI group: 373 patients, mean age: 71 years.<\/span><\/div>\n<div><span> \u2022 CABG group: 80 patients, mean age: 65 years.<\/span><\/div>\n<div><span> \u2022 Median follow-up: 9.3 years (longest follow-up: 14.1 years).<\/span><\/div>\n<div><span> \u2022 Primary outcome: All-cause mortality was significantly lower in the CABG group (68.9%) compared to the PCI group (83.1%).<\/span><\/div>\n<div><span> \u2022 Other outcomes at longest follow-up:<\/span><\/div>\n<div><span> \u2022 Myocardial infarction readmission: 10.2% (CABG) vs. 28.4% (PCI).<\/span><\/div>\n<div><span> \u2022 Repeat revascularization: 3.1% (CABG) vs. 24.4% (PCI).<\/span><\/div>\n<div><span> \u2022 Stroke and all-cause rehospitalization rates showed no significant difference between CABG and PCI.<\/span><\/div>\n<div><\/div>\n<div>Clinical Implications:<\/div>\n<div><span> \u2022 CABG is expected to become the preferred revascularization strategy for patients with TVD and CKD, given its clear survival benefits.<\/span><\/div>\n<div><span> \u2022 The study emphasizes the high morbidity and mortality rates in this population, highlighting the need for perioperative strategies to reduce complications, including renal dysfunction.<\/span><\/div>\n<div><span> \u2022 Multidisciplinary heart teams should individualize treatment decisions, as PCI may still be preferable in select cases based on anatomy and patient-specific factors.<\/span><\/div>\n<div><span> \u2022 While further research is needed, the study strengthens the case for CABG as the gold standard for revascularization in patients with TVD and CKD.<\/span><\/div>\n<div><\/div>\n<div>Reference:<\/div>\n<div><a href=\"https:\/\/www.ajconline.org\/article\/S0002-9149(25)00078-5\/fulltext\">https:\/\/www.ajconline.org\/article\/S0002-9149(25)00078-5\/fulltext<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CABG still the \u2018gold standard\u2019 for revascularization in patients with 3-vessel CAD and CKD. CABG Provides Superior Long-Term Outcomes Compared to PCI in Patients with TVD and CKD Publication was released by the AHA via its official outlets \/February 19, 2025. A new study published in The American Journal of Cardiology confirms that coronary artery [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5904","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=5904"}],"version-history":[{"count":2,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5904\/revisions"}],"predecessor-version":[{"id":5906,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5904\/revisions\/5906"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=5904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=5904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=5904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}